154 related articles for article (PubMed ID: 27101095)
1. Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism.
Petramala L; Iacobellis G; Carnevale R; Marinelli C; Zinnamosca L; Concistrè A; Galassi M; Iannucci G; Lucia P; Pignatelli P; Ciardi A; Violi F; De Toma G; Letizia C
Horm Metab Res; 2016 Jul; 48(7):440-5. PubMed ID: 27101095
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
4. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
[TBL] [Abstract][Full Text] [Related]
5. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
7. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
[TBL] [Abstract][Full Text] [Related]
9. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
Gokulakrishnan K; Deepa R; Mohan V; Gross MD
Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
[TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.
Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L
Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348
[TBL] [Abstract][Full Text] [Related]
11. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis.
Gremmel T; Ay C; Riedl J; Kopp CW; Eichelberger B; Koppensteiner R; Panzer S
Thromb Haemost; 2016 Mar; 115(3):615-21. PubMed ID: 26467184
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?
Tapan S; Dogru T; Tasci I; Ercin CN; Ozgurtas T; Erbil MK
Clin Biochem; 2009 Jun; 42(9):791-5. PubMed ID: 19232335
[TBL] [Abstract][Full Text] [Related]
13. Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients.
Dymicka-Piekarska V; Korniluk A; Gryko M; Siergiejko E; Kemona H
Int J Biol Markers; 2014 Sep; 29(3):e261-7. PubMed ID: 24706377
[TBL] [Abstract][Full Text] [Related]
14. [sCD40L, sP-selectin and sICAM-1 plasma levels in nasopharyngeal carcinoma].
Li L; Li P; Yang YQ; Zhang H; Ai P; Wang F; Jiang Y; Zou LQ; Yan X; Luo F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):513-6. PubMed ID: 19627017
[TBL] [Abstract][Full Text] [Related]
15. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
16. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Kater CE; Biglieri EG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
[TBL] [Abstract][Full Text] [Related]
17. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.
Wu VC; Chueh SC; Chang HW; Lin WC; Liu KL; Li HY; Lin YH; Wu KD; Hsieh BS
QJM; 2008 Jan; 101(1):13-22. PubMed ID: 18203722
[TBL] [Abstract][Full Text] [Related]
18. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
